20962 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons Thrombopoietin
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RADIATION INDUCED TOXICITY
#2Methods for Mitigating Lung Injury in Conjunction with Exposure to Radiation and/or Radiation or Radiomimetic Treatments
#3COMBINATION THERAPY TO TREAT ERYTHROPOIETIN-RESISTANT ANEMIA IN CHRONIC KIDNEY DISEASE
#4INHIBITORS OF CYTOCHROME P450 FAMILY 7 SUBFAMILY B MEMBER 1 (CYP7B1) FOR USE IN MOBILIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS
#5NK CELLS OR T CELLS EXPRESSING CHIMERIC HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND METHODS OF USE
#6METHODS OF INCREASING PROGENITOR CELL PRODUCTION
#7FIBROBLAST-BASED THERAPY FOR TREATMENT AND PREVENTION OF STROKE
#8FIBROBLAST-BASED THERAPY FOR TREATMENT OF SCLEROSING CHOLANGITIS
#9Methods of Enhancing Protection Against Organ and Vascular Injury, Hematopoietic Recovery and Survival in Response to Total Body Radiation/Chemical Exposure
#10COMBINED USE OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND HEMATOPOIETIC GROWTH FACTORS FOR TREATING HEMATOPOIETIC DISEASES
#11PHARMACEUTICAL COMPOSITION FOR TREATING APLASTIC ANEMIA
#12Process for lyophilized pharmaceutical formulations of a therapeutic protein
#13Chimeric Growth Factor Receptors
#14TRANSIENT PROTECTION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AGAINST IONIZING RADIATION
#15METHODS OF TREATMENT WITH PEGFILGRASTIM AND ROMIPLOSTIM
#16METHOD OF TREATING IDIOPATHIC THROMBOCYTOPENIA PURPURA (ITP) WITH ROMIPLOSTIM
#17METHODS OF ENHANCING PROTECTION AGAINST ORGAN AND VASCULAR INJURY, HEMATOPOIETIC RECOVERY AND SURVIVAL IN RESPONSE TO TOTAL BODY RADIATION/CHEMICAL EXPOSURE
#18METHODS FOR MITIGATING LIVER INJURY AND PROMOTING LIVER HYPERTROPHY, REGENERATION AND CELL ENGRAFTMENT IN CONJUNCTION WITH RADIATION AND/OR RADIOMIMETIC TREATMENTS
#19Methods of mitigating toxic effects of vesicants and caustic gas
#20Methods of protecting vascular integrity induced by targeted radiation therapy
#21Combination inhibiting MEIS proteins
#22Use of compounds with thrombopoietic activity to promote bone growth and healing
#23TRANSIENT PROTECTION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AGAINST IONIZING RADIATION
#24PROCESS FOR LYOPHILIZED PHARMACEUTICAL FORMULATION OF A THERAPEUTIC PROTEIN
#25Reagents and methods for detecting PNH type II white blood cells and their identification as risk factors for thrombotic disorders
#26TRANSIENT PROTECTION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AGAINST IONIZING RADIATION
#27AGENT FOR INDUCING AMPLIFICATION OF HEMATOPOIETIC STEM CELLS
#28Reagents and methods for detecting PNH type II white blood cells and their identification as risk factors for thrombotic disorders
#29Transient Protection of Hematopoietic Stem and Progenitor Cells Against Ionizing Radiation
#30Lyophilized pharmaceutical composition of Fc-peptide fusion protein
#31Use of compounds with thrombopoietic activity to promote bone growth and healing
#32ANTAGONISM OF ABCG4, LYN KINASE, AND C-CBL E3 LIGASE TO INCREASE PLATELET COUNT AS THERAPY FOR THROMBOCYTOPENIA
#33Transient Protection of Hematopoietic Stem and Progenitor Cells Against Ionizing Radiation
#34Therapeutic uses of allogeneic myeloid progenitor cells
#35THROMBOPOIETIN RECEPTOR LIGANDS FOR NEUROPROTECTION
#36REAGENTS AND METHODS FOR DETECTING PNH TYPE II WHITE BLOOD CELLS AND THEIR IDENTIFICATION AS RISK FACTORS FOR THROMBOTIC DISORDERS
#37THROMBOPOIETIN MIMETICS FOR THE TREATMENT OF RADIATION OR CHEMICAL INDUCED BONE MARROW INJURY
#38PHARMACEUTICAL COMPOSITION COMPRISING TPO OR AN AGONIST OF THE TPO RECEPTOR
#39Methods And Composition For Treating Heart Failure And Ischemia
#40COMPOUNDS AND METHODS
#41REAGENTS AND METHODS FOR DETECTING PNH TYPE II WHITE BLOOD CELLS AND THEIR IDENTIFICATION AS RISK FACTORS FOR THROMBOTIC DISORDERS
#42Compositions and methods for treatment of thrombosis and for prolonging survival of stored platelets
#43Methods of treating idiopathic thrombocytopenic purpura with compositions comprising extracts of
#44Peptide therapy for increasing platelet levels
#45Antibody therapy
#46MODIFIED HUMAN THROMBOPOIETIN POLYPEPTIDE FRAGMENT AND MANUFACTURING METHOD THEREOF
#47Methods of increasing platelet and hematopoietic stem cell production
#48Method of reducing deleterious effects of ischemia by administration of a thrombopoietin receptor ligand
#49Fibroblast growth factor (FGF) analogs and uses thereof
#50Antibody therapy
#51TISSUE REGENERATION METHOD
#52Thrombopoietic Compounds
#53Therapeutic uses of allogeneic myeloid progenitor cells
#54METHOD AND COMPOSITIONS FOR TREATMENT OF CANCERS
#55Antibody therapy
#56METHODS FOR REDUCING GNRH-POSITIVE TUMOR CELL PROLIFERATION
#57METHOD FOR THE TREATMENT OF RADIATION-INDUCED NEUTROPENIA BY ADMINISTRATION OF A MULTI-PEGYLATED GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) VARIANT
#58Treating idiopathic thrombocytopenic purpura with comprising extracts of
#59INHIBITION OF PACAP SIGNALLING FOR THE PREVENTION AND TREATMENT OF THROMBOCYTOPENIA
#60METHOD FOR INDUCING THROMBOPOIESIS
#61TREATMENT OF RESPIRATORY CHAIN DISORDERS USING COMPOUNDS HAVING ERYTHROPOIETIN OR THROMBOPOIETIN ACTIVITY
#62Method of treating chemotherapy-induced thrombocytopenia
#63Antibody therapy
#64Thrombopoietic compounds
#65Methods for hematopoietic stimulation
#66Compounds to promote regeneration of bone marrow
#67Compounds to promote regeneration of bone marrow
#68Tissue regeneration method
#69ANTIBODY THERAPY
#70Method of reducing the effects of ischemia by administration of a thrombopoietin receptor ligand
#71Therapeutic uses of allogeneic myeloid progenitor cells
#72Use of TPO mimetic compounds and pharmaceutical compositions in the treatment of anemia
#73Inhibition of PACAP signalling for the prevention and treatment of thrombocytopenia
#74Ex-vivo rescue of hematopoietic stem cells after lethal irradiation
#75Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure
#76Methods of increasing platelet and hematopoietic stem cell production